TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Investor Investigation Over Possible Breaches Of Fiduciary Duties In Acquisition Announced

  • Investors who purchased shares of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and currently hold any of those NASDAQ: PGNX shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), was announced concerning whether the takeover of Progenics Pharmaceuticals, Inc. is unfair NASDAQ: PGNX stockholders. The investigation by a law firm concerns whether certain officers and directors of Progenics Pharmaceuticals, Inc. breached their fiduciary duties owe...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: